Seguir
Vasiliki Pelekanou
Vasiliki Pelekanou
Digital Pathology Leader, Oncology Precision Medicine, Bayer Pharmaceuticals
Dirección de correo verificada de bayer.com
Título
Citado por
Citado por
Año
Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
J McLaughlin, G Han, KA Schalper, D Carvajal-Hausdorf, V Pelekanou, ...
JAMA Oncology, 2015
8592015
Immunological differences between primary and metastatic breast cancer
B Szekely, V Bossuyt, X Li, VB Wali, GA Patwardhan, C Frederick, A Silber, ...
Annals of Oncology 29 (11), 2232-2239, 2018
2732018
Quantitative and pathologist-read comparison of the heterogeneity of programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer
JA Rehman, G Han, DE Carvajal-Hausdorf, BE Wasserman, V Pelekanou, ...
Modern Pathology 30 (3), 340-349, 2017
1732017
Estrogen anti-inflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ERα36 and GPR30/GPER1
V Pelekanou, M Kampa, F Kiagiadaki, A Deli, P Theodoropoulos, ...
Journal of Leucocyte Biology 99 (2), 333-347, 2016
1732016
Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological …
VI Alexaki, G Notas, V Pelekanou, M Kampa, M Valkanou, ...
The Journal of immunology 183 (9), 5948-5956, 2009
1252009
Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance
V Pelekanou, DE Carvajal-Hausdorf, M Altan, B Wasserman, ...
Breast Cancer Research 19, 1-11, 2017
1142017
B7-H3 expression in NSCLC and its association with B7-H4, PD-L1 and tumor-infiltrating lymphocytes
M Altan, V Pelekanou, KA Schalper, M Toki, P Gaule, K Syrigos, ...
Clinical Cancer Research 23 (17), 5202-5209, 2017
1132017
Ki67 Reproducibility using Digital Image Analysis: An Inter-platform and Inter-Operator Study
B Acs, V Pelekanou, Y Bai, S Martinez-Morilla, M Toki, S Leung, ...
Laboratory Investigation, 2018
1122018
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
ES Reisenbichler, G Han, A Bellizzi, V Bossuyt, J Brock, K Cole, O Fadare, ...
Modern pathology 33 (9), 1746-1752, 2020
1092020
Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas
V Pelekanou, M Kampa, M Kafousi, K Darivianaki, E Sanidas, DD Tsiftsis, ...
BMC cancer 8, 1-9, 2008
972008
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers
V Pelekanou, F Villarroel-Espindola, ...
Breast Cancer Research 20 (154), 2018
902018
Tumor infiltrating lymphocytes and PD-L1 expression in pre- and post-treatment breast cancers in the SWOG S0800 Phase II neoadjuvant chemotherapy trial
V Pelekanou, WE Barlow, Z Nahleh, B Wasserman, YC Lo, ...
Molecular Cancer Therapeutics, 2018
892018
Membrane-initiated steroid action in breast and prostate cancer
M Kampa, V Pelekanou, E Castanas
Steroids 73 (9-10), 953-960, 2008
832008
TWEAK affects keratinocyte G2/M growth arrest and induces apoptosis through the translocation of the AIF protein to the nucleus
S Sabour Alaoui, V Dessirier, E De Araujo, VI Alexaki, V Pelekanou, ...
PLoS One 7 (3), e33609, 2012
642012
Recent insights into the effect of natural and environmental estrogens on mammary development and carcinogenesis
V Pelekanou, G Leclercq
International Journal of Developmental Biology 55 (7-8-9), 869-878, 2011
632011
Immune profiling of pre-and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trial
X Li, S Warren, V Pelekanou, V Wali, A Cesano, M Liu, P Danaher, ...
Journal for immunotherapy of cancer 7, 1-9, 2019
612019
Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells
G Notas, AP Nifli, M Kampa, V Pelekanou, VI Alexaki, P Theodoropoulos, ...
The Journal of nutritional biochemistry 23 (6), 656-666, 2012
592012
Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells
G Notas, AP Nifli, M Kampa, V Pelekanou, VI Alexaki, P Theodoropoulos, ...
The Journal of nutritional biochemistry 23 (6), 656-666, 2012
592012
ERα36, a new variant of the ERα is expressed in triple negative breast carcinomas and has a specific transcriptomic signature in breast cancer cell lines
V Pelekanou, G Notas, M Kampa, E Tsentelierou, J Radojicic, G Leclercq, ...
Steroids 77 (10), 928-934, 2012
582012
TPL2 kinase is a suppressor of lung carcinogenesis
K Gkirtzimanaki, KK Gkouskou, U Oleksiewicz, G Nikolaidis, D Vyrla, ...
Proceedings of the National Academy of Sciences 110 (16), E1470-E1479, 2013
572013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20